Literature DB >> 14880630

Sodium restriction and cation exchange resin therapy in nephrotic children.

F M MATEER, L H ERHARD, M PRICE, F A WEIGAND, J H PETERS, T S DANOWSKI, R TARAIL, L GREENMAN.   

Abstract

Entities:  

Keywords:  NEPHROSIS/therapy; RESINS

Mesh：

Substances：

Year:  1951        PMID： 14880630      PMCID： PMC436341          DOI： 10.1172/JCI102507

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  15 in total

1.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. VII. CONCENTRATED HUMAN SERUM ALBUMIN.

Authors:  C A Janeway; S T Gibson; L M Woodruff; J T Heyl; O T Bailey; L R Newhouser
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

2.  TRANSFERS OF CELL SODIUM AND POTASSIUM IN EXPERIMENTAL AND CLINICAL CONDITIONS.

Authors:  J R Elkinton; A W Winkler; T S Danowski
Journal:  J Clin Invest       Date:  1948-01       Impact factor: 14.808

3.  Biochemical changes accompanying the ingestion of a carboxylic cation exchanger in the hydrogen, ammonium, sodium, potassium, or calcium form.

Authors:  L GREENMAN; J H PETERS; F M MATEER; F A WEIGAND; D WILKINS; R TARAIL; G RHODES; T S DANOWSKI
Journal:  J Clin Invest       Date:  1951-09       Impact factor: 14.808

4.  Cation exchange resins in the treatment of congestive heart failure.

Authors:  S H HAY; J E WOOD
Journal:  Ann Intern Med       Date:  1950-11       Impact factor: 25.391

5.  Treatment of potassium retention in anuria with cation exchange resin; a preliminary report.

Authors:  J R ELKINTON; J K CLARK; R D SQUIRES; L W BLUEMLE; A P CROSLEY
Journal:  Am J Med Sci       Date:  1950-11       Impact factor: 2.378

6.  The effect of a cation exchange resin on electrolyte balance and its use in edematous states.

Authors:  L IRWIN; E Y BERGER
Journal:  J Clin Invest       Date:  1949-11       Impact factor: 14.808

7.  Dextran in supportive therapy with comments on periston and gelatin.

Authors:  J S LUNDY; H K GRAY; W M CRAIG
Journal:  Arch Surg       Date:  1950-07

8.  Metabolic changes associated with administration of adrenocorticotropin in the nephrotic syndrome.

Authors:  E B FARNSWORTH
Journal:  Proc Soc Exp Biol Med       Date:  1950-05

9.  The effect of nitrogen mustard on renal manifestations of human glomerulonephritis.

Authors:  H CHASIS; W GOLDRING; D S BALDWIN
Journal:  J Clin Invest       Date:  1950-06       Impact factor: 14.808

10.  Treatment of nephrosis with concentrated human serum albumin. II. Effects on renal function and on excretion of water and some electrolytes.

Authors:  J A LUETSCHER; A D HALL; V L KREMER
Journal:  J Clin Invest       Date:  1950-07       Impact factor: 14.808
View more
  8 in total

1.  [Five-year experiences with cation exchange therapy].

Authors:  H P WOLFF
Journal:  Klin Wochenschr       Date:  1954-09-01

2.  RESINS and cardiac oedema.

Authors: 
Journal:  Br Med J       Date:  1953-09-12

3.  [Therapeutic use of kation-exchangers].

Authors:  H HERKEN; M WOLF
Journal:  Klin Wochenschr       Date:  1952-06-15

4.  Ion-exchange Resins.

Authors: 
Journal:  Br Med J       Date:  1954-03-13

5.  The management of the nephrotic syndrome.

Authors:  C M RILEY
Journal:  Bull N Y Acad Med       Date:  1952-10

6.  Probable clinical utility of cation exchange resins.

Authors:  L GREENMAN; J H PETERS; F M MATEER; T S DANOWSKI
Journal:  J Clin Invest       Date:  1951-09       Impact factor: 14.808

7.  Biochemical changes accompanying the ingestion of a carboxylic cation exchanger in the hydrogen, ammonium, sodium, potassium, or calcium form.

Authors:  L GREENMAN; J H PETERS; F M MATEER; F A WEIGAND; D WILKINS; R TARAIL; G RHODES; T S DANOWSKI
Journal:  J Clin Invest       Date:  1951-09       Impact factor: 14.808

8.  An introduction to experimental and clinical studies of carboxylic cation exchange resins.

Authors:  T S DANOWSKI; L GREENMAN; J H PETERS; F M MATEER
Journal:  J Clin Invest       Date:  1951-09       Impact factor: 14.808
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.